RDHL has been in the news 375% more than usual
Dec 05, 2025, 3:32 PM
-13.75%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: The Global Cleanroom Technologies Market is projected to expand from $6.53 billion in 2024 to $10.58 billion by 2031, largely due to demand from the semiconductor and biopharma sectors. Crescent Biopharma, Inc. recently announced a $185 million private placement and a partnership with Sichuan Kelun-Biotech, which impacted its share price.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.